Lates News

ParkHee Biotech (PHH), a skincare management company listed in the US, fell more than 93% to $2.82, hitting a new intraday low since its December 2024 IPO in the United States. The stock had surged 552% year-to-date as of the closing on July 7, reaching a historic high on that day with a market value of $1.1 billion at one point.